Nano-X Imaging Ltd. (NNOX) Income Statement
NNOX 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsNNOX revenue and net income
Where NNOX's revenue goes
2025Each bar shows an amount and its share of revenue. NNOX kept −576.1% of revenue as net income.
NNOX profit margins
NNOX growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +15.4% | +14.9% | — | — |
| Gross profit | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
NNOX quarterly EPS vs estimates
Nano-X Imaging beat the analyst EPS estimate in 3 of the last 8 quarters. Next report: November 19, 2026 (estimate $-0.14).
NNOX income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.0M | $11.3M | $9.9M | $8.6M | $1.3M | $0 | $0 | $0 |
| Cost of revenue | $25.8M | $21.9M | $16.5M | $15.5M | $2.8M | $208,000 | $53,000 | $35,000 |
| Gross profit | −$12.8M | −$10.6M | −$6.6M | −$6.9M | −$1.5M | −$208,000 | −$53,000 | −$35,000 |
| Research & development | $19.2M | $20.2M | $26.0M | $26.5M | $17.1M | $9.2M | $2.7M | $672,000 |
| Sales, general & admin | $27.1M | $25.7M | $28.4M | $45.6M | $41.7M | $34.7M | $19.9M | $1.2M |
| Total operating expenses | $47.9M | $46.1M | $56.0M | $72.3M | $60.0M | $43.9M | $22.6M | $1.9M |
| Operating income | −$60.7M | −$56.7M | −$62.6M | −$109.7M | −$61.6M | −$43.9M | −$22.6M | −$1.9M |
| Interest income | $1.4M | $2.9M | $1.7M | $789,000 | — | — | — | — |
| Interest expense | — | — | — | $60.2M | $2.0M | $108,000 | $8,000 | $5,000 |
| Income before taxes | −$76.8M | −$53.9M | −$61.1M | −$108.9M | −$61.8M | −$43.8M | −$22.6M | −$1.9M |
| Income taxes | −$1.8M | −$358,000 | −$339,000 | −$3.7M | −$48,000 | −$316,000 | −$8,000 | $5,000 |
| Net income | −$75.0M | −$53.5M | −$60.8M | −$105.2M | −$61.8M | −$43.5M | −$22.6M | −$1.9M |
| EBITDA | −$49.0M | −$45.0M | −$47.7M | −$75.7M | −$59.3M | −$43.7M | −$22.5M | −$1.9M |
| EPS (diluted) | −$0.64 | −$0.67 | −$1.07 | −$2.02 | −$1.06 | −$0.33 | −$0.51 | −$0.09 |
| Gross margin | −98.2% | −94.0% | −66.6% | −80.2% | −116.0% | — | — | — |
| Operating margin | −466.2% | −502.9% | −631.9% | −1,279.0% | −4,720.7% | — | — | — |
| Net margin | −576.1% | −474.3% | −613.6% | −1,226.9% | −4,739.1% | — | — | — |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.2M | $4.3M | $3.7M | $3.4M | $3.0M | $2.8M | $3.0M | $3.0M | $2.7M | $2.6M | $2.4M | $2.5M |
| Cost of revenue | $47.8M | $7.0M | $7.6M | $6.3M | $6.3M | $5.9M | $5.9M | $5.8M | $5.6M | $4.7M | $4.1M | $4.1M |
| Gross profit | −$43.7M | −$2.7M | −$3.9M | −$2.9M | −$3.2M | −$3.0M | −$2.9M | −$2.8M | −$2.9M | −$2.2M | −$1.7M | −$1.7M |
| Research & development | $4.7M | $4.8M | $4.8M | $4.6M | $4.8M | $5.0M | $5.4M | $4.7M | $4.8M | $5.2M | $6.8M | $6.0M |
| Sales, general & admin | $5.4M | $7.4M | $7.9M | $6.8M | $6.4M | $6.1M | $6.6M | $6.6M | $6.8M | $5.8M | $5.5M | $6.2M |
| Total operating expenses | $11.8M | $12.1M | $12.6M | $11.4M | $11.3M | $11.0M | $18.0M | $11.3M | $11.5M | $10.9M | $11.5M | $12.9M |
| Operating income | −$55.5M | −$14.8M | −$16.5M | −$14.2M | −$14.5M | −$14.1M | −$15.0M | −$14.1M | −$14.5M | −$13.1M | −$13.3M | −$22.0M |
| Interest income | — | $369,000 | $351,000 | $457,000 | — | $765,000 | $820,000 | $404,000 | $856,000 | $790,000 | $360,000 | $511,000 |
| Interest expense | — | — | — | — | $149,000 | — | — | — | — | — | — | — |
| Income before taxes | −$55.5M | −$14.2M | −$35.1M | −$13.8M | −$14.6M | −$13.3M | −$14.2M | −$13.7M | −$13.7M | −$12.3M | −$10.3M | −$21.5M |
| Income taxes | −$51,000 | $76,000 | −$1.7M | −$94,000 | $82,000 | −$86,000 | — | −$94,000 | −$76,000 | −$94,000 | −$79,000 | −$79,000 |
| Net income | −$55.5M | −$14.3M | −$33.4M | −$13.7M | −$14.7M | −$13.2M | −$14.1M | −$13.6M | −$13.6M | −$12.2M | −$10.2M | −$21.4M |
| EBITDA | −$52.7M | −$12.0M | −$14.1M | −$11.3M | −$11.5M | −$11.1M | — | −$11.2M | −$11.5M | −$10.2M | −$7.6M | −$11.7M |
| EPS (diluted) | −$0.79 | −$0.20 | −$0.17 | −$0.15 | −$0.17 | −$0.15 | −$0.17 | −$0.15 | −$0.14 | −$0.21 | −$0.18 | −$0.37 |
| Gross margin | −1,050.9% | −62.6% | −105.2% | −83.6% | −106.6% | −108.3% | −96.3% | −92.8% | −105.7% | −84.3% | −71.6% | −67.0% |
| Operating margin | −1,334.9% | −343.1% | −443.7% | −413.0% | −476.7% | −500.5% | −499.2% | −466.5% | −537.5% | −512.5% | −553.0% | −887.2% |
| Net margin | −1,335.1% | −330.9% | −897.4% | −397.0% | −484.3% | −470.3% | −468.7% | −450.0% | −503.0% | −479.5% | −427.5% | −863.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in NNOX's financial statements (latest annual report filed April 30, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
NNOX financial results
In fiscal year 2025 (ended December 31, 2025), Nano-X Imaging reported revenue of $13.0 million, up 15.4% from the year before. It had a net loss of $75.0 million, a net profit margin of −576.1%. Diluted earnings per share came to −$0.64.
See the NNOX stock overview for the latest quote and news, or the NNOX chart for price history and technical indicators.
NNOX income statement FAQ
What is Nano-X Imaging's annual revenue?
Nano-X Imaging reported total revenue of $13.0 million for fiscal year 2025, which ended on December 31, 2025. That was up 15.4% from $11.3 million the previous year.
Is Nano-X Imaging profitable?
No. Nano-X Imaging reported a net loss of $75.0 million in fiscal 2025, a net profit margin of −576.1%; its operating margin was −466.2%.
What is Nano-X Imaging's gross margin?
Nano-X Imaging's gross margin was −98.2% in fiscal 2025: for every $100 of revenue, Nano-X Imaging kept $-98 after the direct cost of its products and services.
How much does Nano-X Imaging spend on research and development?
Nano-X Imaging spent $19.2 million on research and development in fiscal 2025, 147.7% of revenue.
What are Nano-X Imaging's earnings per share?
Nano-X Imaging earned $-0.64 per diluted share in fiscal 2025, compared with $-0.67 a year earlier.
When will Nano-X Imaging report its next earnings?
Nano-X Imaging is expected to report results for the quarter ending September 30, 2026 on November 19, 2026 before the market opens.
When does Nano-X Imaging's fiscal year end?
Nano-X Imaging's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on April 30, 2026.